Penza, 28 August 2015. PenzaNews. “Biosintez,” a medication producer in the Penza region, has good import replacement potential if it expands its retail market and improves production volumes, suggested Ivan Belozertsev during his visit to the enterprise early on Friday, August 28.

© PenzaNewsBuy the photo

He was personally escorted through the location by the general director Dmitry Boldov and his assistant Lyudmila Leontyeva, and accompanied by the acting deputy chairman of the regional government Valery Bespalov and the regional Industry Ministry chief Mikhail Torgashin.

The head management showed the guests an injection medication conveyor with the maximum capacity of 18,000 doses per hour, a QC laboratory, and a packaging line.

Ivan Belozertsev asked questions about the imported production goods, such as glass packaging for the doses: according to Dmitry Boldov, it is mostly supplied from Kursk and Poltava.

Answering the question of the acting governor about the supply routes to the local medication store chains, the director pointed out that it is actively promoted by “Farmatsiya” and constitutes 60% of the region’s hospital medication stock.

“So, that means other medical institutions in other regions should buy your medicine that has the same content for less price?” the head of the region suggested.

Dmitry Boldov explained that all medication us bought using procurement procedures, and the situation is confined within the starting cost of the contract.

“If we cannot fit the cost price in, we do not take part in them. If a customer is ready to buy product off of us for 30 rubles, and the maximum cost set by the client is 20 rubles, even 20.05 would be impossible. […] Wherever we can fit, we sign in using cost prices and win auctions. The problem is, we no longer produce 40 types of medicine out of 180,” he noted.

Ivan Belozertsev also asked several questions about labor conditions, salary levels and product assortment.

After the guided tour, Ivan Belozertsev meet the workers of “Biosintez.”